SHELTON CAPITAL MANAGEMENT - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 105 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$1,009,196
-44.6%
160,700
-7.0%
0.11%
+21.8%
Q3 2022$1,823,000
+84.5%
172,800
-5.1%
0.09%
+97.7%
Q2 2022$988,000
-40.9%
182,0000.0%0.04%
-29.0%
Q1 2022$1,671,000
-39.1%
182,0000.0%0.06%
-36.1%
Q4 2021$2,746,000
-16.6%
182,000
+31.9%
0.10%
-24.8%
Q3 2021$3,294,000138,0000.13%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,014,78515.70%
Memorial Sloan Kettering Cancer Center 544,196$2,312,8337.30%
Elmwood Wealth Management, Inc. 2,364,415$10,048,7644.68%
PFM Health Sciences, LP 5,570,869$23,676,1930.92%
Avidity Partners Management LP 2,758,600$11,724,0500.41%
Green Alpha Advisors, LLC 105,826$449,7600.30%
Bruce & Co., Inc. 200,000$850,0000.24%
SVB FINANCIAL GROUP 20,714$88,0350.17%
Rokos Capital Management LLP 2,748,139$11,202,7890.11%
Tekla Capital Management LLC 567,147$2,410,3750.09%
View complete list of CARIBOU BIOSCIENCES INC shareholders